Posts

STAT+: New weight loss drugs have proven their effectiv...

A team of researchers will soon launch a study driven by a pressing question in ...

STAT+: 3 medtech trends to watch in 2024

STAT looks at the forces that shaped the medical devices industry last year, and...

In situ characterization reveals different dehydrogenat...

They published their work on Dec. 20 in Energy Material Advances. Credit: Wen Zh...

Virtual care works best when patients see their own fam...

Toronto, ON, December 27, 2023 – Compared to patients who had a virtual visit wi...

A study of the genetics of pericarditis increases under...

A study of the genetics of pericarditis increases understanding of newly approve...

Scientists use organoid model to identify potential new...

A drug screening system that models cancers using lab-grown tissues called organ...

Asian Fund for Cancer Research announces Degron Therape...

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron The...

AZD-9550 by AstraZeneca for Metabolic Dysfunction-Assoc...

AZD-9550 is under clinical development by AstraZeneca and currently in Phase I f...

GS-4528 by Gilead Sciences for Metastatic Renal Cell Ca...

GS-4528 is under clinical development by Gilead Sciences and currently in Phase ...

ADRX-0706 by Adcentrx Therapeutics for Head And Neck Sq...

ADRX-0706 is under clinical development by Adcentrx Therapeutics and currently i...

BGB-30813 by BeiGene for Head And Neck Squamous Cell Ca...

BGB-30813 is under clinical development by BeiGene and currently in Phase I for ...

NT-175 by Neogene Therapeutics for Head And Neck Squamo...

NT-175 is under clinical development by Neogene Therapeutics and currently in Ph...

ORB-011 by Orionis Biosciences for Head And Neck Squamo...

ORB-011 is under clinical development by Orionis Biosciences and currently in Ph...

ODM-212 by Orion for Solid Tumor: Likelihood of Approval

ODM-212 is under clinical development by Orion and currently in Phase I for Soli...

KB-707 by Krystal Biotech for Solid Tumor: Likelihood o...

KB-707 is under clinical development by Krystal Biotech and currently in Phase I...

RO-7566802 by Genentech USA for Solid Tumor: Likelihood...

RO-7566802 is under clinical development by Genentech USA and currently in Phase...